Clinical studies have documented reductions in total and free testosterone levels, increases in SHBG, and improvements in menstrual regularity following treatment with liraglutide or semaglutide
Although the hypoglycemic effects were similar among the three BMI groups, it was intriguing to find that the HbA1c reduction in the normal BMI patients tended to be greater than that in the obese patients
Csonka is eager to look through evidence based journals, articles to provide accurate, scientifically backed medical data in the relevant scientific fields
usually most pronounced during dose escalation Diarrhea : Affects 12-17% of patients, typically mild to moderate in severity Vomiting : Reported in 6-10% of patients, more common at higher doses Constipation : Occurs in 6-11% of patients Abdominal pain and dyspepsia : Generally transient Decreased appetite : An expected pharmacological effect contributing to weight loss Other documented adverse effects include injection site reactions, hypoglycemia (when used with insulin or sulfonylureas), and less commonly, fatigue
Overcorrection can make the face look puffy and distorted from the rest of the body